SYDNEY GARST: Open Payments
NPI 1942087853 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 39 payments from 14 companies in 2025. Trend: 2023 $17 · 2024 $528 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $172 |
| HEARTFLOW, INC. | 2 | $167 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| ABIOMED | 1 | $123 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $100 |
| Kestra Medical Technology Services, Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Medtronic, Inc. | 1 | $33 |
| CVRx, Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
Products named: FFRct, LEQVIO, LifeVest, CAMZYOS, Assure WCD, ELIQUIS, FARXIGA, SYMPLICITY G3.
Industry payments across GA — which companies pay providers there.
